Power analysis to detect treatment effects in longitudinal clinical trials for Alzheimer's disease

Consideration of the multivariate/joint distribution of components' scores rather than the distribution of a single composite score when designing clinical trials can lead to an increase in power and reduced sample sizes for detecting treatment effects in clinical trials for early AD.